Ignite Creation Date:
2025-12-24 @ 1:41 PM
Ignite Modification Date:
2026-02-02 @ 2:02 AM
Study NCT ID:
NCT01496495
Status:
COMPLETED
Last Update Posted:
2020-09-09
First Post:
2011-11-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes
Sponsor:
Array Biopharma, now a wholly owned subsidiary of Pfizer
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Myelodysplastic Syndromes | View |
Keywords: